78. Фёдоров В.Д., Воробьёв Г.И. Мегаколон у взрослых / АМН СССР. - М.:

Медицина, 1986, 224 с., ил.

79. Фролькис А.В. Запор и его лечение // Клин.мед.- 1979.- №3.- С.112-117.

80. Фролькис А.В. Функциональные заболевания желудочно-кишечного тракта. -

Л.: Медицина, 1991. - 224 с.: ил.

81. Хаммад Е.В. Хронический запор (тактика совершенствования диагностики и

лечения). Дис…к.м.н., М.,1997, с.134.

82. Хаммад Е.В., Григорьева Г.А., Михайлов А.Н. Роль психогенного фактора

в развитии хронических запоров. Сб.: Новое в гастроэнтерологии, М.,

1995, Т.2, с.93-4.

83. Циммерман Я.С. Хронический запор. Диарея: диагностика и лечение. –

Пермь, ПГМА, 1999, с.119.

84. Шамарин П.И. Хронические запоры. - Саратов, 1967. - С.42.

85. Шамарин П.И.: Хронические запоры: происхождение, лечение. - Санаторно-

курортная терапия, Саратов, 1968.

86. Шарон Н. В кн.: Перспективы биохимических исследовании. Под ред. Д.

Туз и С. Прентис. М.: Мир, 1987, с. 180-8.

87. Шендеров Б.А. Медицинская микробная экология и функциональное питание.

М., 1998, Т.1-3.

88. Эседов Э.М. Отдалённый прогностический эффект лечения при хроническом

неязвенном колите и дискинезии толстой кишки. Тер.архив., 1985, №6,

с.96-8.

89. Яремчук А.Я., Кушнирук С.В., Радолицкий С.Е., Дубенко Е.М.

Консервативная терапия хронических колостазов. Клин.медицина, 1988,

№3, с.28-31.

90. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation

scoring system to simplify evaluation and management of constipated

patients. Dis Colon Rectum 1996; 39:681-685.

91. Aichbichler BW, Wenzl HH, Santa Ana CA, Porter JL, Schiller LR,

Fordtran JS. A comparison of stool characteristics from normal and

constipated people, Dig Dis Sci, 43 (11):2353-62 1998 Nov

92. Allescher HD. Laxatives and prokinetics – good or bad? In:

Constipation and anorectal insufficiency. Falk Symposium 95. Kluwer

Academic Publishers; 1997; p.121-129.

93. Anderson AS. Constipation during pregnancy. Incidence and methods used

in its treatment in a group of Cambridgeshire women. J Health Visitor

1984;57:363.

94. Andrews PJ, Bames P, Borody TJ. Chronic constipation reversed by

restoration of bowel flora. Eur J Gastroenterol Hepatol. 1992;4:245-7.

95. Arhan P, Devroede G, Jehannin B, et al. Segmental colonic transit

time. Dis Colon Rectum 1981;24:625-9.

96. Attar A; Lemann M; Ferguson A; Halphen M; Boutron M-C; Flouriґe B;

Alix E; Salmeron M; Guillemot F; Chaussade S; Menard AM; Moreau J;

Naudin G; Barthet M. Comparison of a low dose polyethylene glycol

electrolyte solution with lactulose for treatment of chronic

constipation. Gut 1999 Feb,44(2):226-30.

97. Baessler K, Schuessler B. Constipation and fecal incontinence in the

female. In: Constipation and anorectal insufficiency. Falk Symposium

95. Kluwer Academic Publishers; 1997; p.202-210.

98. Bak YT, Kim JH, Lee CH. Cisapride in chronic idiopathic constipation:

clinical response and effect on colonic transit time. Korean J Intern

Med. 1996 Jun. 11(2):151-6.

99. Baldonedo YC; Lugo E; Uzcґategui AA; Guelrud M; Skornicki J.

Evaluation and use of polyethylene glycol in constipated patients. G E

N 1991 Oct-Dec, 45(4):294-7.

100. Barbara L, Corinaldesi R, Gizza G, Stanghellini V, eds. Chronic

constipation. Philadelphia: Saunders, 1996.

101. Barnes PR. Lennard-Jones JE. Balloon expulsion from the rectum in

constipation of different types. Gut 1985:26:1049-1052.

102. Barrett JA. Fecal incontinence and constipation in the elderly. In:

Constipation and anorectal insufficiency. Falk Symposium 95. Kluwer

Academic Publishers; 1997; p.211-226.

103. Bartram CI, Turnbull GK, Lennard-Jones JE. Evacuation proctography: an

investigation of rectal expulsion in 20 subjects without defecatory

disturbance. Gastrointest Radiol 1988;13:72-80.

104. Bartolo DC. Functional obstructed defecation. Eur J Gastroenterol

Hepatol 1994;6:971-974.

105. Bassotti G, Crowell MD, Whitehead WE. Contractile activity of the

human colon: lessons from 24 hour studies. Gut 1993:34:129-133.

106. Bassotti G.Manometry: why, when and how? In: Constipation and

anorectal insufficiency. Falk Symposium 95. Kluwer Academic

Publishers; 1995; p.68-77.

107. Bassotti G; Chiarioni G; Vantini I; Morelli A; Whitehead WE. Effect

of different doses of erythromycin on colonic motility in patients

with slow transit constipation. Z Gastroenterol, 36(3):209-13 1998

Mar.

108. Berkelmans I, Heresbach D, Leroi A, Touchais J, Martin P, Weber J,

Denis P. Perineal descent at defecography in women with straining at

stool: a lack of specificity or predictive value for future anal

incontinence? Eur J Gastroenterol Hepatol 1995:7:75-79.

109. Berman IR, Manning DH, Harris MS, Streamlining the management of

defecation disorders. Dis Colon Rectum, 1990, 33(9), 778-85.

110. Binder HJ, Cummings J, Soergel K. edit. Short chain fatty acids/ Falk

Symposium 73; Kluwer Academic Publishers, 1994, p.236.

111. Bjelke E. Epidemiologie studies of cancer of the stomach, colon and

rectum. Scand I Gastroenterol 9(Suppl):31, 1974.

112. Bleijenberg G, Kuijpers HC. Treatment of the spastic pelvic floor

syndrome with biofeedback. Dis Colon Rectum 1987,36:108-11.

113. Bouchoucha M, Devroede G, Arhan P, Strom B, Weber J, Cugnenc P-H,

Denis P, Barbier J-P. What is the meaning of colorectal transit time

measurement? Dis Colon Rectum 1992;35:773-782.

114. Bour H: Fibres Alimentaires et constipation // Rev. Franc.

Gastroenterol.- 1984.- No.197.-p. 114-119.

115. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation

of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in

healthy humans. Gut 1999;44:682-686.

116. Bouras EP, Camilleri M, Burton DD, Thomforde G. Prucalopride

accelerates gastrointestinal and colonic transit in patients with

constipation without rectal evacuation disorder. Gastroenterology

2001;120:652-668.

117. Browning SM: Constipation, diarrhea, and irritable bowel syndrome.

Primary Care; Clinics in Office Practice, vol.26, N.2, March 1999.

118. Bruckschen E, Horosiewicz H. Chronische Obstipation. Vergleich von

mikrobiologischer Therapie und Lactulose. Mьnch Med Woschenschr.

1994;136:241-5.

119. Burleigh DE. Evidence for a functional cholinergic deficit in human

colonic tissue resected for constipation. J Pharm Pharmacol, 40:55-7,

1988 Jan

120. Camilleri M, Choi M-G. Review article: irritable bowel syndrome.

Aliment Pharmacol Ther 1997; 11: 3-15.

121. Camilleri M. Management of the irritable bowel syndrome.

Gastroenterology 2001;120:652-668.

122. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat

bran in patients with irritable bowel syndrome? Gut 1984;25:165-173.

123. Celik AF, Tomlin J, Read NW. The effect of oral vancomycin on chronic

idiopathic constipation. Aliment Pharmacol Ther. 1995;9:63-8.

124. Chadwick VS et Phillips SF. // Gastroenterology, 1982, v.2.

125. Chaussade S, Roche H, Khyardi A, et al. A new method for measuring

colonic transit time. Description and validation. Gastroenterol Clin

Biol 1986;10:385-389.

126. Chaussade S. Determination of total and segmental colonic transit time

in constipated patients. Results in 91 patients with a new simplified

method. Dig Dis Sci 34:1168-1172, 1989 Aug.

127. Chiotakakou-Faliakou E; Kamm MA; Roy AJ; Storrie JB; Turner IC.

Biofeedback provides long-term benefit for patients with intractable,

slow and normal transit constipation. Gut, 42(4):517-21 1998 Apr.

128. Chong-Liang HE, Burghardt L, Wang L, Pemberton J et al. Decreased

intestinal cell of Cojal volume in patients with slow-transit

constipation. Gastroenterology, 2000;118:14-21.

129. Connell AM, Hilton C, Irvine G, et al. Variation in bowel habit in two

population samples. Br Med J 1965;2:1095.

130. Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P,

Mastropaolo G et al. Long term efficacy, safety, and tolerabilitity of

low daily doses of isosmotic polyethylene glycol electrolyte balanced

solution (PMF-100) in the treatment of functional chronic

constipation. Gut 2000;46:522-526 (April)

131. Coremans G, Kerstens R, Woods M. Dose-ranging efficacy, safety and

tolerability of prucalopride in patients with chronic constipation:

Results of two randomized, placebo-controlled, double-blind trials. Am

J Gastroenterol 1999;94(9):2669 (Abstract).

132. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N,

Cedarbaum JM. Recombinant Human Neurotrophic Factors Accelerate

Colonic Transit and Relieve Constipation in Humans. Gastroenterology

2000;119:41-50.

133. Couturier D. Comparative study of Forlax and Transipeg in the

treatment of functional constipation in the adult. Ann Gastroenterol

Hepatol (Paris), 1996 May-Jun, 32:135-40.

134. Cremerius J. Die Prognose funktioneller Syndrome.- Leipzig, 1968,

s.134.

135. Сummings J., Kelly M.J., Smith C.L.: The significance of propulsive,

retropulsive and segmenting contractions of the colon and rectum in

the irritable bowel syndrome // Gut.- 1983.- Vol.24.- P.368-368.

136. Cummings JH. Quantitating short chain fatty acid production in humans.

In: Short chain fatty acids/ Falk Symposium 73; Kluwer Academic

Publishers, 1994, 11-19.

137. Davies GJ, Crowder M, Reid B, Dickerson JWT. Bowel function

measurements of individuals with different eating patterns. Gut

1986;27:164.

138. de Graaf EJ; Gilberts EC; Schouten WR. Role of segmental colonic

transit time studies to select patients with slow transit constipation

for partial left-sided or subtotal colectomy. Br J Surg, 83(5):648-51

1996 May

139. Delvaux M, Frexinos J. A European approach to irritable bowel syndrome

management. Can J Gastroenterol 1999 Mar;13 Suppl A:85A-88A.

140. Devroede G. Constipation. In: Sleisenger MH, Fordtran JS, eds.

Gastrointestinal disease: pathophysiology, diagnosis and management.

4th ed. Philadelphia: WB Saunders, 1989:331.

141. Diamant NE, Kamm MA, Wald A, et al. American Gastroenterologic

Association technical review on anorectal testing techniques.

Gastroenterology 1999;116:735-60.

142. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MvB. A

randomized, placebo-controlled, multicenter study of the safety and

efficacy of Braintree 851 laxative. Am J Gastroenterol (abstract)

1997;92:1674.

143. DiPalma JA, MacRae DH, Reichelderfer M, Hamilton JW, Cleveland MvB.

Braintree polyethylene glycol (PEG) laxative for ambulatory and long-

term care facility constipation patients: report of randomized, cross-

over trials. Braintree Laboratories Inc., Braintree, MA;

http://www.ojdh.org/current.dir/dipalma%5Fbraintree.html

144. Dodds WJ, Dent J, Hogan WJ. Pregnancy and the lower esophageal

sphincter. Gastroenterology 1978;74:1334.

145. Drossman DA, Sandler RS, McKee DC, et al: Bowel patterns among

subjects not seeking health care. Use of a questionnaire to identify a

population with bowel dysfunction. Gastroenterology 83:529-534, 1982.

146. Drossman DA, ed. The functional gastrointestinal disorders. Boston:

Little, Brown, 1994:115-173.

147. Drossman DA Diagnosing and treating patients with refractory

functional gastrointestinal disorders. Ann Intern Med 1995;123:688-

693.

148. Drossman DA, Creed FH, Fava GA, Olden KW, Patrick DL, Toner BB,

Whitehead WE. Psychosocial aspects of the functional gastrointestinal

disorders. Gastroenterology International 1995;8:47-90.

Страницы: 1, 2, 3, 4